None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 18-35 years, gender is not limited; 2. No cognitive impairment measured by Mini Mental State Scale (MMSE) and Montreal Cognitive Assessment (MoCA); 3. GDS self-rating depression scale evaluation without depression; 4. Functional activity questionnaire (FAQ), BADL daily living ability scale (barthel index) showed normal activity; 5. Agree to participate in this study and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Local skin infections, ulcers, scars or those who are overly sensitive to electrical stimulation; 2. Severe bleeding disorders and coagulation disorders; 3. History of epilepsy or seizures; first-degree relatives with history of epilepsy; 4. Metal implants on the body or head above the chest (except for stomatology), implanted with cardiac pacemaker defibrillators, cochlear implants, and drug pumps; 5. Unexplained recurrent headaches that are ineffective for drug treatment or taking tricyclic antidepressants, neuroleptics and other drugs that lower the seizure threshold; 6. Skull fracture and/or severe head injury; history of head and/or brain surgery; 7. Other diseases or medical history affecting cognitive function; 8. Those with severe visual or hearing impairment who cannot cooperate with the assessment; 9. Those with a history of smoking and alcoholism; 10. Pregnant or lactating patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation indicators related to transcranial magnetic stimulation (TMS); | — |
Secondary
| Measure | Time frame |
|---|---|
| Nonlinear dynamics analysis of EEG; | — |
Countries
China